Sahnan, Kapil, Tozer, Phil J, Adegbola, Samuel O, Lee, Matthew J, Heywood, Nick, McNair, Angus G K, Hind, Daniel, Yassin, Nuha, Lobo, Alan J., Brown, Steven R., Sebastian, Shaji, Phillips, Robin K S., Lung, Phillip F C., Faiz, Omar D., Crook, Kay, Blackwell, Sue, Verjee, Azmina, Hart, Ailsa L., Fearnhead, Nicola S. and Hargest, Rachel ORCID: https://orcid.org/0000-0001-9830-3832 2018. Developing a core outcome set for fistulising perianal Crohn's disease. Gut 10.1136/gutjnl-2017-315503 |
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution Non-commercial. Download (593kB) | Preview |
Abstract
Objective Lack of standardised outcomes hampers effective analysis and comparison of data when comparing treatments in fistulising perianal Crohn’s disease (pCD). Development of a standardised set of outcomes would resolve these issues. This study provides the definitive core outcome set (COS) for fistulising pCD. Design Candidate outcomes were generated through a systematic review and patient interviews. Consensus was established via a three-round Delphi process using a 9-point Likert scale based on how important they felt it was in determining treatment success culminating in a final consensus meeting. Stakeholders were recruited nationally and grouped into three panels (surgeons and radiologists, gastroenterologists and IBD specialist nurses, and patients). Participants received feedback from their panel (in the second round) and all participants (in the third round) to allow refinement of their scores. Results A total of 295 outcomes were identified from systematic reviews and interviews that were categorised into 92 domains. 187 stakeholders (response rate 78.5%) prioritised 49 outcomes through a three-round Delphi study. The final consensus meeting of 41 experts and patients generated agreement on an eight domain COS. The COS comprised three patient-reported outcome domains (quality of life, incontinence and a combined score of patient priorities) and five clinician-reported outcome domains (perianal disease activity, development of new perianal abscess/sepsis, new/recurrent fistula, unplanned surgery and faecal diversion). Conclusion A fistulising pCD COS has been produced by all key stakeholders. Application of the COS will reduce heterogeneity in outcome reporting, thereby facilitating more meaningful comparisons between treatments, data synthesis and ultimately benefit patient care.
Item Type: | Article |
---|---|
Date Type: | Published Online |
Status: | Published |
Schools: | Medicine |
Additional Information: | Rachel Hargest part of the the ENiGMA collaborators. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license |
Publisher: | BMJ Publishing Group |
ISSN: | 0017-5749 |
Date of First Compliant Deposit: | 30 July 2018 |
Date of Acceptance: | 18 December 2017 |
Last Modified: | 04 May 2023 05:07 |
URI: | https://orca.cardiff.ac.uk/id/eprint/113632 |
Citation Data
Cited 54 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |